SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yong Han Paik, Ja Kyung Kim, Do Young Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon, Kwan Sik Lee, Clinical Efficacy of a 24-months Course of Lamivudine Therapy in Patients with HBeAg Negative Chronic Hepatitis B: A Long-term Prospective Study, Journal of Korean Medical Science, 2010, 25, 6, 882

    CrossRef

  2. 2
    T. Asselah, O. Lada, P. Marcellin, Résultats des essais thérapeutiques dans l’hépatite chronique B, Antibiotiques, 2010, 12, 1, 42

    CrossRef

  3. 3
    Hyun Wook Jung, Moon Seok Choi, Kap Hyun Kim, Sung Hyun Park, Kwak Keum Yeon, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Virologic response to adefovir dipivoxil monotherapy is not durable in HBeAg-positive, lamivudine-resistant chronic hepatitis B patients, The Korean Journal of Hepatology, 2009, 15, 1, 52

    CrossRef

  4. 4
    David L. Veenstra, Sean D. Sullivan, Ming-Yang Lai, Chuan-Mo Lee, Chia-Ming Tsai, Kavita K. Patel, HBeAg-Negative Chronic Hepatitis B: Cost-Effectiveness of Peginterferon Alfa-2a Compared to Lamivudine in Taiwan, Value in Health, 2008, 11, 2
  5. 5
    Manoj Kumar, Shiv K Sarin, Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection, Expert Review of Gastroenterology & Hepatology, 2008, 2, 4, 465

    CrossRef

  6. 6
    T. Asselah, O. Lada, N. Boyer, M. Martinot, P. Marcellin, Traitement de l’hépatite chronique B, Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 749

    CrossRef

  7. 7
    Holbrook E. Kohrt, Daniel L. Ouyang, Emmet B. Keeffe, Antiviral Prophylaxis for Chemotherapy-Induced Reactivation of Chronic Hepatitis B Virus Infection, Clinics in Liver Disease, 2007, 11, 4, 965

    CrossRef

  8. 8
    Anna S. F. Lok, Brian J. McMahon, Chronic hepatitis B, Hepatology, 2007, 45, 2
  9. 9
    Kwan Sik Lee, Dong Joon Kim, Management of Chronic Hepatitis B, The Korean Journal of Hepatology, 2007, 13, 4, 447

    CrossRef

  10. 10
    Haifeng Geng, Bing Hua, Hua Wang, Yanhong Cao, Yun Sun, Airong Yu, Dual-probe assay for detection of lamivudine-resistance hepatitis B virus by real-time PCR, Journal of Virological Methods, 2006, 132, 1-2, 25

    CrossRef

  11. 11
    Marc G. Ghany, T. Jake Liang, Natural history of hbeag-negative chronic Hepatitis b, Current Hepatitis Reports, 2006, 5, 1, 27

    CrossRef

  12. 12
    Anastasia Rivkin, A review of entecavir in the treatment of chronic hepatitis B infection, Current Medical Research and Opinion, 2005, 21, 11, 1845

    CrossRef

  13. 13
    Marc Bourlière, Portage inactif du virus de l’hépatite B, Gastroentérologie Clinique et Biologique, 2005, 29, 4, 369

    CrossRef

  14. 14
    JUNG WOO SHIN, YOUNG-HWA CHUNG, MIN HEE CHOI, JEONG A KIM, SOO HYUNG RYU, MYOUNG KUK JANG, IN SOOK KIM, NEUNG HWA PARK, HAN CHU LEE, YUNG SANG LEE, DONG JIN SUH, Precore stop codon mutation of hepatitis B virus is associated with low breakthrough rate following long-term lamivudine therapy, Journal of Gastroenterology and Hepatology, 2005, 20, 6
  15. 15
    Rosamar E.F. Rezende, Benedito A.L. Fonseca, Leandra N.Z. Ramalho, Sérgio Zucoloto, João Renato R. Pinho, Dennis A. Bertolini, Ana L.C. Martinelli, The precore mutation is associated with severity of liver damage in Brazilian patients with chronic hepatitis B, Journal of Clinical Virology, 2005, 32, 1, 53

    CrossRef

  16. 16
    Chien-Hung Chen, Chuan-Mo Lee, Jing-Houng Wang, Hung-Da Tung, Chao-Hung Hung, Sheng-Nan Lu, Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers, European Journal of Gastroenterology & Hepatology, 2004, 16, 11, 1213

    CrossRef

  17. 17
    Peter Karayiannis, Current therapies for chronic hepatitis B virus infection, Expert Review of Anti-infective Therapy, 2004, 2, 5, 745

    CrossRef

  18. 18
    Alessia Ciancio, Antonina Smedile, Mario Rizzetto, Marco Lagget, John Gerin, Brent Korba, Identification of HBV DNA sequences that are predictive of response to lamivudine therapy, Hepatology, 2004, 39, 1
  19. 19
    Giovanna Fattovich, Natural history of hepatitis B, Journal of Hepatology, 2003, 39, 50

    CrossRef

  20. 20
    Giuseppe Rossi, Prophylaxis with Lamivudine of Hepatitis B Virus Reactivation in Chronic HbsAg Carriers with Hemato-oncological Neoplasias Treated with Chemotherapy, Leukemia & Lymphoma, 2003, 44, 5, 759

    CrossRef

  21. 21
    Ruth Chin, Stephen Locarnini, Treatment of chronic hepatitis B: current challenges and future directions, Reviews in Medical Virology, 2003, 13, 4
  22. 22
    Anna S. Lok, E.Jenny Heathcote, Jay H. Hoofnagle, Management of hepatitis B: 2000—Summary of a workshop, Gastroenterology, 2001, 120, 7, 1828

    CrossRef

  23. 23
    Ming-Shen Dai, Jang-Jih Lu, Yeu-Chin Chen, Cherng-Lih Perng, Tsu-Yi Chao, Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients, Cancer, 2001, 92, 11
  24. 24
    J.N. Zuckerman, A.J. Zuckerman, Current Topics in Hepatitis B, Journal of Infection, 2000, 41, 2, 130

    CrossRef